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Shiga toxin (Stx) follows a complex intracellular pathway in order to kill susceptible cells. After binding to
cell surface glycolipids, the toxin is internalized and trafficked in retrograde fashion to the endoplasmic
reticulum (ER). From the ER lumen, the toxin must gain access to the cytoplasm, where it enzymatically
inactivates the 28S rRNA, inhibiting protein synthesis. The host molecules involved in this pathway and the
mechanisms utilized by the toxin to access the cytoplasm from the ER are largely unknown. We found that Stx
is capable of energy-dependent transport across the ER lumen, as has recently been demonstrated for the
cholera and ricin toxins. Genetic screening for molecules involved in Shiga toxin trafficking yielded a cDNA
encoding a prematurely truncated protein. Characterization of this cDNA revealed that it encodes a novel
Hsp40 chaperone, designated HEDJ or ERdj3, localized to the ER lumen, where it interacts with BiP, a
molecule known to be involved in protein retrotranslocation out of the ER. We demonstrated that within the
ER lumen Stx interacts with HEDJ and other chaperones known to be involved in retrotranslocation of
proteins across the ER membrane. Moreover, sequential immunoprecipitation revealed that Shiga toxin was
present in a complex that included HEDJ and Sec61, the translocon through which proteins are retrotrans-
located to the cytoplasm. These findings suggest that HEDJ is a component of the ER quality control system
and that Stx utilizes HEDJ and other ER-localized chaperones for transport from the ER lumen to the cytosol.
Bacterial toxins, by their very nature, are remarkably adept
at exploiting host cell biology (7, 17, 20). Shiga toxins (Stx),
which are responsible for thousands of cases of hemorrhagic
colitis annually and are the causative agents of hemolytic-
uremic syndrome, provide a dramatic example. Intracellular
trafficking of Stx appears to take advantage of two recently
described quality control pathways. After binding to receptors
on the cell surface, Shiga toxin is internalized, and rather than
being routed to the lysosome for degradation, the toxin follows
a novel retrograde pathway through the Golgi apparatus to the
lumen of the endoplasmic reticulum (ER), presumably riding a
preexisting membrane recycling pathway (25, 26). From the
lumen of the ER, the A subunit of Stx (StxA) must gain access
to the cytoplasm. Unlike some other bacterial toxins (such as
diphtheria toxin and the anthrax toxins), Shiga toxin has no
intrinsic ability to cross host membranes and therefore is pre-
sumed to utilize host machinery to cross intracellular mem-
branes. It has recently been proposed that such toxins gain
access to the cytoplasm via a retrograde pathway normally
utilized for export of misfolded host proteins from the ER (4,
23, 27).
The ER is an important site of protein quality control. Mo-
lecular chaperones such as BiP, an Hsp70 chaperone, assist in
protein import and folding within the ER lumen (12–14, 32).
Nascent proteins that do not fold correctly are transported for
degradation from the ER lumen to the cytosol via a translocon,
Sec61, in a process that also requires BiP (6, 18, 19). In Sac-
charomyces cerevisiae, this process is also known to require
members of the Hsp40 family (16). The mechanisms by which
proteins are recognized as misfolded and then recruited to
Sec61 for reverse translocation are currently unknown. How-
ever, these processes are under intense scrutiny because sev-
eral human diseases result either from pathological retention
of misfolded proteins in the ER or degradation of proteins,
such as CFTRF508, that are functional but never reach the cell
surface because of misfolding and degradation by quality con-
trol systems in the ER (10, 37, 38).
Recent evidence has implicated the ER quality control sys-
tem in the intracellular trafficking of some bacterial toxins. For
example, the cholera and ricin toxins are trafficked in retro-
grade fashion to the ER lumen. Like Stx, these toxins lack
pore-forming activity. Instead, both have recently been dem-
onstrated to undergo reverse translocation through the Sec61
translocon in order to reach the cytoplasm (26, 27, 29, 33, 35).
It has been proposed that StxA, like the ricin and cholera
toxins, is able to mimic the structure of a misfolded protein and
thereby utilize the host translocation machinery for transport
from the ER to the cytosol.
We demonstrate here that the Stx A subunit, like the sub-
units of the cholera and ricin toxins, is capable of retrotrans-
location across the ER membrane. A screening approach was
utilized to identify host genes involved Shiga toxin trafficking.
Through toxin selection and sequential enrichment, this ap-
proach yielded cDNA encoding a novel, truncated protein. We
subsequently isolated the entire gene, which encoded a protein
that we designated HEDJ (also known as ERdj3), and dem-
onstrated that the protein is an ER-localized Hsp40 chaperone
(36). Transfection of Vero cells with a truncated cDNA en-
coding only the amino-terminal 126 amino acids of HEDJ
resulted in diminished Stx susceptibility. In order to determine
whether HEDJ was capable of interacting with Stx within the
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ER lumen, an in vitro assay was utilized. Within the ER lumen
and prior to transport, the toxin was found to interact with
HEDJ, BiP, and Grp94. Sequential immunoprecipitation dem-
onstrated that a portion of the toxin associated with HEDJ was
also associated with Sec61. Our results demonstrated that
there was an interaction with HEDJ prior to its transport
across the ER membrane. Based on similarities between
HEDJ and related molecules in the yeast ER, we suggest here
that the normal role of HEDJ may be recruitment of misfolded
proteins to the Sec61 translocon and that Stx is capable of
exploiting this function of HEDJ for its own transport across
the ER membrane.
MATERIALS AND METHODS
Cell lines and antibodies. Vero cells (African green monkey adult kidney cells;
ATCC CCL-81; American Type Culture Collection, Bethesda, Md.) were main-
tained in Dulbecco’s modified Eagle’s medium containing 10% fetal calf serum
(Gibco BRL, Grand Island, N.Y.).
Plasmid pHED7, which includes 92 bp of 5untranslated region and encodes
the first 121 amino acids of HEDJ fused to the V5 epitope and a histidine tag,
was created by amplifying the HEDJ gene with primers GFP-1 and Hsp-4
(5CCTGTTCTTGCTGACGAGGGGTTCC-3) and cloning in frame into plas-
mid pCR3.1V5/His/Topo (Invitrogen).
In order to generate affinity-purified antiserum, peptides corresponding to
regions of StxA and HEDJ were synthesized by Biosynthesis Inc. (Galveston,
Tex.) and were purified by high-performance liquid chromatography. A cysteine
residue was added at either the amino or carboxyl terminus of each peptide. The
corresponding peptide sequences were CCEAREGIKQLLKQGSVQKVYNG
LQGY for HEDJ and CDVRGIDPEEGRFNNLR for StxA. A peptide consist-
ing of amino acids PGPTPSGTNC, derived from Sec61 and described previ-
ously (34), was also synthesized. Peptides were conjugated to maleimide-
activated keyhole limpet hemocyanin (Pierce Corp.), dialyzed against phosphate-
buffered saline (PBS), and then used to immunize two rabbits (Cocalico
Biolgicals). After the third booster dose, 25 ml of serum was passed over peptide
immobilized on Sulfolink beads (Pierce Corp.). After washing, affinity-purified
antibodies were eluted with 100 mM glycine (pH 2.5), neutralized, and then
dialyzed against PBS. Polyclonal rabbit antiserum was raised against purified
StxB, as previously described (2).
Shiga toxin preparation. Semipurified Stx-1 was prepared from Escherichia
coli harboring the genes encoding Shigella dysenteriae Stx-1 on plasmid pNAS13
(generously provided by Alison O’Brien), which contained the operon on a
3.4-kb NcoI fragment from pNAS4 (30). Two-liter cultures of the bacteria were
grown overnight at 37°C. Periplasmic extraction was performed by osmotic shock
(15). The periplasmic extract was concentrated to 10 ml and then subjected to
anion-exchange chromatography on a Q-Sepharose column by using a gradient
from 20 mM Tris (pH 7.5) to 20 mM Tris (pH 7.0)–1 M NaCl. Fractions
containing StxA, as judged by dot blotting, were pooled and purified further by
gel filtration by using a Superdex 75 HR 10/30 column equilibrated with PBS.
Immunoreactive fractions were again pooled and stored frozen. Western blotting
revealed the presence of StxA and StxB in the pooled sample. Coomassie blue
staining of the pooled sample indicated that the protein concentration was
approximately 5 g/ml and the toxin purity was approximately 30%. Serial
dilution of the semipurified Stx revealed cytotoxic activity against Vero cells even
at a 1:10,000 dilution.
Generation of a Vero cell cDNA library. mRNA was isolated from approxi-
mately 1  108 Vero cells. First-strand cDNA was synthesized by addition of
random hexamer primers and avian myeloblastosis virus reverse transcriptase.
Second-strand synthesis was performed, the ends were blunted with T4 DNA
polymerase, nonpalindromic BStxI adapters (Invitrogen) were ligated to the
cDNA ends, and the resulting cDNA was then size selected (500 bp) by agarose
gel electrophoresis. The adapter-ligated cDNA was recovered and ligated into
BstxI-digested expression plasmid pcDNAI (Invitrogen). In this bidirectional
library, each cDNA could have been ligated in the sense or antisense orientation.
The ligated cDNA library was then electroporated into E. coli strain MC1061/P3
and plated on 30 15-cm petri dishes containing ampicillin and tetracycline. The
next day, bacterial colonies were harvested, aliquoted, and stored at 20°C.
Cloning of full-length HEDJ cDNA. In order to identify the 3 transcriptional
termination site of the HEDJ gene, 3 rapid amplification of cDNA ends was
performed. cDNA that was obtained from human skeletal muscle and was ligated
to adapters whose sequences were known was used in the reaction (Clontech). A
PCR was performed with a primer internal to the sequence of HEDJ (GFP-1;
5-GGCCTCACAGGGCCGGGTGGGCTGG-3) and another primer pur-
chased from Clontech that recognized the ligated adapter (AP-1). A second
round of PCR was performed with nested primers, which again consisted of a
gene-specific primer (HSP-5; 5-GCTTCATC-CCGACCGGAACCCTGAT-3)
and another primer that recognized the adapter (AP-2; Clontech). The product
was subcloned, and the nucleotide sequence, which contained the putative stop
codon, was determined. As a complementary means of identifying the start and
stop codons, iterative BLAST searches were performed against the human EST
database. By successive walking in both directions, several overlapping sequences
in the human EST database were identified. No additional putative start codons
were identified 5 to the codon already identified, and in the other direction the
entire coding sequence could be identified. This sequence matched that obtained
by 3 rapid amplification of cDNA ends. A primer complementary to and over-
lapping the stop codon (5-TCACTCTCAATATCCT-TGCAGTCCATTGTAT
ACC-3) was used along with primer GFP-1 to amplify the entire HEDJ coding
region from skeletal muscle cDNA. As described previously, nucleotide sequenc-
ing of the PCR product revealed the presence of an 1,175-bp insert encoding a
protein consisting of 359 amino acids (36). We subsequently demonstrated that
the cDNA encoded a putative signal peptide, a highly conserved J domain, and
other features of Hsp40 chaperones (36).
Shiga toxin cytotoxicity assays. For cytotoxicity studies, approximately 5  105
Vero cells were transfected with either empty pCR3.1 vector (wild-type control)
or plasmid pHED-7 encoding amino acid residues 1 to 126 of HEDJ and bearing
a V5 epitope and a six-His tag (36). Transfections were performed by using 50 l
of lipofectamine (Gibco BRL) and a suspension containing 3 g of plasmid
DNA. Forty-eight hours later, neomycin (Gibco BRL) was added to the medium
to a concentration of 1,000 gm/ml, and neomycin-resistant clones were allowed
to proliferate for 14 days.
Shiga toxin inhibits protein synthesis in susceptible cells (17). In order to
determine the effect of Stx on wild-type and pHED-7-transfected cells, protein
synthesis assays were carried out. Wild-type or pHED-7-transfected cells were
suspended in triplicate in 400 l of replete medium, and 2.5  104 cells were
placed in each well in a 24-well dish. The following day, cells were either left
untreated or exposed for 4 h to Stx at a 1:100 dilution in complete medium. Cell
monolayers were then washed two times with PBS and incubated in Cys/Met-free
medium containing [35S]Cys/Met (ICN Biomedicals, Inc., Costa Mesa, Calif.) at
a concentration of 10 Ci/ml. The cells were incubated for 30 min at 37°C and
then washed six times in PBS and lysed by addition of 500 l of 0.2% sodium
dodecyl sulfate (SDS) in 50 mM Tris-HCl (pH 7.5). Trichloroacetic acid (TCA)
was added to a concentration of 10%, and the samples were incubated on ice for
30 min. After a 10-min centrifugation at 14,000  g, the supernatant was re-
moved, and the pellet was washed in 10% TCA and then transferred to a
scintillation tube. Incorporation of [35S]Cys/Met, as an indication of de novo
protein synthesis after toxin exposure, was determined by scintillation counting
of precipitated lysates. In order to determine whether the [35S]Cys/Met incor-
poration in untreated and treated cells was significantly different, a statistical
analysis was performed by using the paired two-tailed t test.
In vitro transcription and translation of Shiga toxin. In order to translate the
wild-type StxA gene, we utilized an E. coli coupled transcription-translation
system (Promega Corp., Madison, Wis.) rather than the more commonly used
rabbit reticulocyte lysate because we found that the de novo-synthesized toxin
was very active and inactivated rabbit ribosomes efficiently and the toxin yields
were extremely poor. Moreover, in order to allow toxin translocation into the ER
lumen during translation, the StxA signal peptide was replaced with a eukaryotic
signal peptide known to be cleaved by signal peptidase during protein import into
the ER (derived from the immunoglobulin G gene). This was done by PCR by
using 5 primer ST-17 (5-AATATGGGTTGGTCATGTATTATTCTGTTCCT
GGTAGCAACTGCAACTGGGGTTCATTCGCAGGTTCAGCTGAAGGAA
TTTACCTTAGACTTC-3), which was optimized for E. coli codon usage, and
primer ST-9 (5-GCAGGCGGCCGCCCTCAACTGCTAATAGTTCTGCGC-3).
The resulting product, encoding the signal peptide from the immunoglobulin G
chain, the signal peptidase cleavage site, and the mature Shiga toxin A subunit, was
ligated into plasmid pT7-7 to create plasmid pST17/9 and allowed in vitro transcrip-
tion with T7 RNA polymerase.
Microsomes (containing ER fragments) were prepared by scraping approxi-
mately 5  106 Vero cells into 3 ml of PBS. The cells were sedimented by
centrifugation, resuspended in 1 ml of isotonic buffer (25 mM HEPES, 110 mM
KCl; pH 6.8), and subjected on ice to 30 strokes in a Dounce homogenizer.
Nuclei were removed by centrifugation at 2,000  g for 5 min, and the micro-
somal fraction was then pelleted either by centrifugation at 14,000  g for 5 min
or by addition of MgCl2 to a concentration of 20 mM, incubation on ice for 10
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min, and centrifugation at 6,000  g for 5 min. Microsomal pellets were resus-
pended in 50 l of isotonic buffer.
Coupled in vitro transcription and translation were carried out by using the E.
coli T7 S30 extract system (Promega Corp.) according to the manufacturer’s
recommendations. Each 50-l reaction mixture contained 1 g of plasmid
pST17/9, 5 l of microsomes, and 30 Ci of [35S]methionine.
Protease protection and luciferase assays. Protease protection assays were
carried out as described previously (36). Coupled transcription and translation
reactions were carried out in the presence of 5 l of microsomes by using an E.
coli T7 S30 extract as described above. After this, the microsomes were harvested
by centrifugation and then washed once in 100 l of PBS by centrifugation at
10,000  g for 5 min and removal of the supernatant. The microsomal pellet was
resuspended in 50 l of PBS alone or PBS containing 1% Triton X-100. To two
of the samples, proteinase K was added to a final concentration of 100 g/ml.
The samples were incubated on ice for 30 min and then boiled and subjected to
SDS-polyacrylamide gel electrophoresis (PAGE). The gels were fixed, soaked in
Enlightening solution (NEN DuPont), and dried as described above. StxA was
detected by fluorography.
In order to determine whether translated StxA within microsomes was enzy-
matically active, protein synthesis inhibition assays were carried out. First, StxA
was translated into microsomes as described above. Control reaction mixtures
contained either no plasmid or empty pCRT7 cloning vector. After coupled
transcription and translation as described above, microsomes were harvested by
centrifugation at 10,000  g for 5 min. The microsomal pellet was resuspended
in 100 l of PBS containing 0.1% Triton X-100. One microliter of each of the
preparations was added to a second in vitro transcription and translation reaction
mixture in which rabbit ribosomes were used to transcribe and translate the
luciferase protein. The reactions were performed with the TNT T7 coupled
reticulocyte lysate system (Promega Corp.) and the control luciferase expression
plasmid, as described in the manufacturer’s recommendations. However, before
the luciferase expression plasmid was added, reticulocyte lysates were treated for
15 min at 37°C with 1 l of the microsomal extract derived from StxA or control
translation reactions. After this, luciferase plasmid DNA was added, and the
reactions were allowed to proceed for 30 min. Five microliters of each reaction
product was added to 100 l of luciferase substrate (luciferase assay system;
Promega Corp.), and the light output was quantified with a luminometer.
Shiga toxin transport assays. Transport assays were carried out by using a
modification of in vitro assays for cholera toxin translocation (27). Radioactive
Stx was loaded into the ER lumen by in vitro transcription and translation in the
presence of 5 l of microsomes. The toxin-loaded microsomes were then washed
in PBS and resuspended in 100 l of transport buffer containing ATP and an
ATP-regenerating system (2 mM MgCl2, 2 mM ATP, 20 mM creatine phosphate,
400 g of creatine kinase per ml in PBS) on ice. For control reactions, the loaded
microsomes were resuspended in PBS lacking ATP or an ATP-regenerating
system. The transport reaction mixtures were incubated for various times ranging
from 0 to 120 min at 37°C. Samples were centrifuged at 14,000 g for 5 min, and
the supernatant (containing transported toxin) was removed from the microso-
mal pellet. The samples were boiled with Laemmli buffer, subjected to SDS-
PAGE, and imaged by fluorography.
Coimmunoprecipitation of Stx with ER-localized chaperones. In order to
examine the interaction of Stx with various ER-localized chaperones, coimmu-
noprecipitation reactions were carried out with antibodies against HEDJ, Sec61,
BiP, protein disulfide isomerase (PDI), and Grp94. Immunoprecipitation was
performed by pelleting microsomes by centrifugation after in vitro transcription
and translation. Prior to immunoprecipitation, one-half of a sample was sub-
jected to cross-linking by resuspending it in 2 mM dithiobis(succinimidylpropi-
onate) (DSP) in PBS and incubating the preparation on ice for 30 min. Cross-
linked and uncross-linked microsomes were washed with cold PBS and lysed in
0.5 ml of lysis buffer (1% Triton X-100, 0.5% NaDoC, 10 mM EDTA in PBS).
For the cross-linked product, 25 mM glycine was added. The samples were
precleared by addition of 0.15 ml of protein G in bovine serum albumin wash
buffer (1% bovine serum albumin, 1% SDS, 1% Triton X-100, 0.5% NaDoC in
PBS). After incubation for 1 h at 4°C, the protein G was removed by centrifu-
gation. Approximately 2 g of the appropriate anti-chaperone antibody was
added, and each sample was incubated overnight at 4°C. The next day, protein G
(0.15 ml) was added, and after incubation for 1 h at 4°C, immunoprecipitated
antigen and protein G were recovered by centrifugation, washed several times in
bovine serum albumin wash buffer, and then resuspended in gel loading buffer
and subjected to SDS-PAGE. The gel was fixed, soaked in Enlightening solution
(NEN Dupont), dried, and exposed to film to detect coimmunoprecipitated
radiolabeled Stx. Control experiments demonstrated that none of the anti-chap-
erone antibodies cross-reacted with in vitro-translated StxA (data not shown).
RESULTS
Phenotypic cloning of HEDJ. In an attempt to identify host
genes involved in Shiga toxin trafficking, we used an approach
that should have disrupted the normal trafficking pathway and
thereby rendered cells relatively resistant to the toxin. Whereas
cell death requires up to 48 h of toxin exposure, we hoped to
use a more rapid and quantitative assay for toxin resistance.
Since Stx inhibits protein synthesis (20), we anticipated that
treatment of cells expressing a destabilized green fluorescent
protein (dGFP), designated d2EGFP, with Stx would result in
decreased de novo synthesis of d2EGFP. Existing protein
would be degraded, and in the absence of ongoing protein
synthesis, fluorescence would be lost from toxin-susceptible
cells. In contrast, toxin-resistant cells were expected to con-
tinue dGFP synthesis in the presence of Stx and thereby re-
main fluorescent. Resistant cells could be separated from sus-
ceptible cells by fluorescence-activated cell sorting (FACS).
Vero cells were stably transfected with plasmid pd2EGFP-
N1,l and FACS and immunofluorescence were used to select
cells that had cytoplasmic expression of green fluorescent pro-
tein. In order to demonstrate that inhibition of protein synthe-
sis resulted in loss of fluorescence over time, control experi-
ments with cycloheximide were performed. Vero:d2EGFP
cells were treated with cycloheximide (final concentration, 10
mM) and examined either by fluorescence microscopy or by
FACS at various times. Maximal loss of fluorescence occurred
after exposure of cells for 12 to 18 h to cycloheximide. The
abilities of cycloheximide and Shiga toxin to decrease the flu-
orescence of d2EGFP:Vero cells were then compared. After
12 h of exposure to either Shiga toxin or cycloheximide, fluo-
rescence was markedly decreased in d2EGFP-expressing cells
(Fig. 1B).
In order to randomly impair gene expression or function, a
cDNA library was created in the sense and antisense orienta-
tions. The library was calculated to contain 1.4  106 indepen-
dent cDNA clones. Restriction digestion of 20 randomly se-
lected clones revealed that the average insert size was
approximately 0.8 kb. It was anticipated that high-level expres-
sion of an antisense mRNA might decrease the amount of an
endogenous mRNA that encoded a product involved in toxin
trafficking. In addition, since the library was created from ran-
dom primed cDNA, it was anticipated that the cDNA library
contained predominantly truncated messages. Expression of a
truncated protein or antisense message might have a dominant
negative effect on an endogenous protein involved in toxin
internalization or trafficking and thereby enable toxin resis-
tance. By either mechanism, transfecting cells with the random
primed, bidirectional cDNA library might have conferred toxin
resistance on a small number of cells.
In order to enrich for cDNA clones that enabled toxin re-
sistance, the contents of 10 100-mm3 dishes, each containing
approximately 1  106 Vero:dGFP cells, were transfected with
the Vero cDNA library (2.5 g) by using lipofectamine (50 l).
The library was cotransfected with plasmid pSVE (0.4 g),
which encodes the simian virus 40 large T antigen, driving
high-level replication of plasmids containing the Vero cDNA
library.
Approximately 48 h after transfection, cells were harvested
and replated in the presence of Shiga toxin (1:100 dilution of
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semipurified extract; approximately 15 ng of toxin per ml).
Eighteen hours later the cells were harvested and subjected to
fluorescence-activated cell sorting such that the 1% of cells
that retained the most fluorescence was separated. Plasmid
DNA was isolated by Hirt extraction (5) from the FACS-sorted
Vero:dGFP cells and then electroporated into E. coli
MC1061/P3 and plated onto medium containing ampicillin and
tetracycline (which did not allow replication of transformants
containing the pSVE large T plasmid, which encodes only
ampicillin resistance). Plasmid DNA, representing cDNA
FIG. 1. (A) Schematic drawing of the phenotypic cloning approached used to isolate HEDJ. Vero cells stably expressing destabilized green
fluorescent protein (Vero:dGFP) were transfected with a Vero cell cDNA library and then exposed to toxin. After 18 h of incubation,
toxin-resistant cells were separated from susceptible cells by FACS. Plasmid DNA was recovered from enriched cells by Hirt extraction and were
subjected to another two rounds of transfection and enrichment. (B) FACS profile demonstrating the baseline fluorescence of untreated
Vero:dGFP cells and cells treated for 18 h either with cycloheximide or with Shiga toxin. The region gated by M1 included less than 1% Vero cells
lacking green fluorescent protein expression. (C) Schematic representation of the HEDJ gene product. The residues enriched by phenotypic
cloning and included in plasmid pHED-7 are indicated by the dotted line. The locations of the J domain, the glycine- and phenylalanine-rich
domain (G/F region), and the cysteine-rich domain found in most Hsp40 chaperones (36) are indicated.
VOL. 73, 2005 TRANSPORT OF Stx FROM ER 2527
 o
n
 February 8, 2014 by W







clones enriched through toxin selection, was used in a second
round of transfection of Vero:dGFP cells, toxin exposure, and
sorting by FACS as described above. A second Hirt extract was
obtained from enriched fluorescent cells, electroporated, and
used for a third round of transfection and enrichment. How-
ever, after the third transfection, cells were incubated in the
presence of toxin (1:100 dilution of semipurified toxin) for
48 h. The medium was changed, and fresh toxin (1:100 dilu-
tion) was added in order to select for cells that were stably
transfected with cDNAs putatively encoding toxin resistance.
After several days, very few viable cells were evident. The cells
that were present appeared to be vacuolated, grew slowly, and
did not form large colonies as cells became rounded and de-
tached almost at the same rate that cells divided and replaced
dying cells. This phenotype persisted for more than 48 h after
toxin was removed from the medium, likely indicating a toxic
effect of the expressed cDNA.
Hirt extraction could not be used to isolate DNA from these
stably transfected cells, as the plasmid DNA was presumed to
have integrated into the genome. Instead, in order to deter-
mine whether these Stx-resistant cells contained a Vero cDNA
insert, the cells were harvested, centrifuged, and resuspended
in 50 l of water. Five microliters of the total cell extract was
subjected to PCR by using primers T7 and Sp6, which flanked
inserts in plasmid pcDNAI. Two bands at approximately 600
and 200 bp were visualized. As a control, cells transfected with
pSVE, which lacked T7 and Sp6 priming sites, were subjected
to PCR with the same primers. No product was visualized
when these cells were used as the DNA source. The PCR
products from Stx-resistant cells were directly subcloned into
vector pCR3.1/Topo (Invitrogen). After transformation into E.
coli, approximately 30 colonies were isolated. Plasmid DNA
was isolated from six of the colonies, and the nucleotide se-
quences were determined.
When the sequences were compared with the GenBank da-
tabase by using the program BLAST, there were no matches.
However, when two of the resulting clones were compared
with the human EST database, two entries matched with very
high sequence identities. We previously described an initial
characterization of the gene product, which we designated
HEDJ and has also been called ERdj3 (1, 28).
Expression of a truncated HEDJ results in decreased sus-
ceptibility to Stx. The HEDJ cDNA isolated from Stx-resistant
cells consisted of the start codon and sequences encoding the
signal peptide, the J domain, and a portion of the linker region,
but it did not encode the full-length protein. In order to dem-
onstrate the effect of truncated HEDJ on Stx susceptibility in
naı¨ve cells, Vero cells were transfected with an epitope-tagged,
truncated HEDJ. The truncated molecule used here was nearly
identical to that isolated in the original screening analysis and
lacked the carboxyl terminus, which in other Hsp40 chaper-
ones is thought to be the substrate binding portion. The J
domain was expressed here intact and is known to be able to
bind BiP (36). After transfection with truncated HEDJ, cells
were selected with neomycin for 2 weeks. Control cells were
transfected with the cloning vector alone and likewise were
selected with neomycin for 2 weeks. Notably, the cells express-
ing truncated HEDJ had a phenotype similar to that of the
cells isolated after the third round of cDNA enrichment with
toxin. In particular, within individual colonies, some cells be-
came rounded and detached, resulting in a lower rate of pro-
liferation and sparse colonies. Moreover, we were not able to
select stable cells that expressed the truncated HEDJ encoded
by plasmid pHED-7, since after approximately 2 weeks the
viability of the cells was markedly compromised as cells pro-
liferated but lacked detectable HEDJ expression, as judged by
immunofluorescence and Western blotting. Instead, we uti-
lized cells approximately 14 days after pHED-7 transfection in
the susceptibility assays.
Cells were then assayed for toxin susceptibility by using
inhibition of protein synthesis as a quantitative indicator. Wild-
type Vero cells, which are exquisitely susceptible to Stx (11),
exhibited an 82% decrease in protein synthesis upon exposure
to Shiga toxin. In contrast, cells transfected with truncated
HEDJ were significantly less susceptible, exhibiting a decrease
in protein synthesis of only 24% (Fig. 2). These results dem-
onstrated that expression of truncated HEDJ resulted in re-
duced susceptibility to Stx and were consistent the hypothesis
that truncated HEDJ acts in a dominant-negative manner to
inhibit the function of native HEDJ during toxin transport
from the ER. In order to directly corroborate a role for HEDJ
in toxin trafficking, we attempted to decrease HEDJ mRNA
expression by RNA inhibition. Despite using a stable inhibitory
RNA expression system, we observed only a transient decrease
in HEDJ mRNA, and there was only a minimal effect on the
HEDJ protein levels, as judged by Western blotting. Features
of HEDJ expression and protein stability apparently conspired
to make RNA inhibition unsuccessful, as the expression of
HEDJ mRNA is inducible under ER stress conditions and the
HEDJ protein has a long half-life (approximately 36 h) (N.
Marcus and D. B. Haslam, unpublished data). Instead, in sup-
port of a role for this chaperone in toxin trafficking, we exam-
ined the interaction between Stx and HEDJ within the ER
after first demonstrating that the toxin was capable of translo-
cation across the ER membrane.
FIG. 2. Cells transfected with pHED-7 exhibit reduced susceptibil-
ity to Shiga toxin. Vero cells were transfected with either plasmid alone
(WT) or plasmid a containing truncated HEDJ cDNA (pHED-7).
Neomycin-resistant cells were selected for 2 weeks and then exposed to
Shiga toxin for 4 h. The cells were pulsed with [35S]methionine for 30
min in methionine-free medium. After several washes, the cells were
lysed, TCA was added to a concentration of 10%, and the amount of
radioactivity incorporated into protein was quantified by scintillation
counting of the TCA precipitate. Two asterisks indicate that the dif-
ference in [35S]methionine incorporation between untreated and toxin-
treated wild-type cells is statistically significant (P 	 0.05).
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StxA translocation from the endoplasmic reticulum. In or-
der to determine whether Stx, like the cholera and ricin toxins,
is capable of translocation across the ER membrane, an in
vitro assay was developed. The in vitro approach used by other
investigators to study ER translocation of misfolded host pro-
teins (such as factor H, CFTRF508, and alpha-1-antitrypsin)
was modified in order to examine Stx transport. Radiolabeled
StxA was incorporated into the ER lumen by in vitro transcrip-
tion and translation. Microsomes loaded with radioactive StxA
were washed after translation and then resuspended in trans-
port buffer containing an ATP-regenerating system (or in the
absence of ATP, as a control for nonspecific loss of toxin from
microsomes). The microsomes were incubated at 37°C for var-
ious times, and microsomes were separated from supernatants
(which contained toxin translocated out of the ER) by centrif-
ugation. In most experiments, transported toxin appeared as a
doublet. The higher-molecular-weight form corresponded to
full-length toxin, whereas the lower-molecular-weight form
likely represented the cleaved form of the toxin (the A1 form).
The A1 form, which is the product of proteolytic cleavage prior
to transport out of the ER of living cells, has a molecular mass
of 27.5 kDa (3, 9).
Whereas essentially no toxin was translocated in the absence
of ATP, as expected, toxin was detected the supernatant in the
presence of ATP (Fig. 3). The amount of toxin transported
into the supernatant was time and ATP dependent. The
amount of toxin translocated in these in vitro assays (approx-
imately 5% over 2 h) was not markedly different than the
amount reported for cholera toxin under similar conditions
(27). In summary, we demonstrated in vitro here for the first
time that StxA, like the cholera and ricin toxins, is capable of
energy-dependent retrotranslocation across the ER mem-
brane.
Interaction of Stx with ER-localized chaperones. In order to
determine whether StxA was capable of interaction with HEDJ
or other intraluminal chaperones, an in vitro assay for toxin
translocation was utilized. This assay allowed us to examine
events that occurred in the ER separate from earlier stages in
intoxication, including binding and trafficking to the ER. Sim-
ilar assays have enabled researchers to obtain direct evidence
for the involvement of Sec61 in retrotranslocation of misfolded
human proteins and are currently used to study ER-associated
translocation and degradation of the cystic fibrosis transmem-
brane regulator, alpha-1-antitrypsin, prion proteins, and other
proteins involved in human disease. Recently, a similar in vitro
approach was used to demonstrate that cholera toxin is ex-
ported from the ER via Sec61 (27).
Transport of nascent proteins into the ER lumen during
translation depends on the presence of a eukaryotic signal
peptide. In order to import the Shiga toxin A subunit into
microsomes in the in vitro system, the bacterial signal peptide
was replaced with a eukaryotic signal peptide. In addition, a
signal peptidase cleavage site was placed adjacent to the signal
peptide, so that the mature StxA translated in vitro would have
a sequence identical to that of native mature StxA expressed in
E. coli. The signal peptide and cleavage site derived from
human immunoglobulin G were added to the StxA mature
peptide by PCR by using a 5 primer that encoded the 22
amino acids of the signal peptide and cleavage site. Initial in
vitro translation experiments were plagued by poor toxin
yields; however, when the sequence encoding the signal pep-
tide was revised and optimized for E. coli codon usage, the
resulting construct enabled abundant in vitro translation of
recombinant StxA.
In most other studies in which proteins are cotranslationally
translocated into microsomes, rabbit reticulocyte lysate is used
in the translation reaction. However, StxA potently inactivates
eukaryotic ribosomes, and rabbit reticulocyte lysate could not
be used in these experiments, a feature that we utilized later to
demonstrate that in vitro-translated toxin was enzymatically
active. Instead, E. coli lysate containing T7 RNA polymerase
was found to efficiently transcribe and translate the Shiga toxin
A subunit. Although not previously reported to our knowledge,
E. coli ribosomes were able to efficiently mediate cotransla-
tional import of translated protein into the mammalian ER
lumen.
In order to demonstrate that StxA translated in this system
was efficiently incorporated into the ER lumen, protease pro-
tection assays were performed. StxA was synthesized by cou-
pled in vitro transcription and translation in the presence of
35S-labeled methionine and cysteine and ER extracts as de-
scribed above. The microsomal extract was aliquoted into
three tubes and exposed either to no proteinase K or deter-
gent, to both proteinase K and Triton X-100, or to proteinase
K without detergent. After 30 min of incubation, the reaction
mixtures were subjected to SDS-PAGE and fluoroscopy to
detect residual toxin. Whereas there was minimal degradation
of StxA in the absence of detergent, addition of detergent
resulted in permeabilization of the ER membrane and com-
plete proteolysis of the toxin (Fig. 4A). These results indicate
that the recombinant StxA translated in vitro was protected
from protease and that the toxin was present in the ER lumen.
During intoxication of human cells, Stx is presumed to be
folded and in its enzymatically active state upon entry into the
ER. Unlike host proteins that are translocated across the ER
membrane by chaperones in the ER quality control system, Stx
apparently can subvert this pathway for its own translocation,
FIG. 3. StxA is transported across the ER membrane in an ATP-
dependent manner. StxA was synthesized by coupled in vitro transcrip-
tion and translation in the presence of ER extracts and 35S-labeled
methionine and cysteine as described previously. Microsomes were
then washed in PBS and resuspended in buffer lacking ATP or con-
taining ATP and an ATP-regenerating system. After 30, 60, or 90 min
of incubation at 37°C, microsomes were separated from the superna-
tant, and all samples were boiled and subjected to SDS-PAGE. The
toxin remaining in the microsomes (Retained) and the toxin trans-
ported into the supernatant (Transported) were detected by fluorog-
raphy.
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even when it is correctly folded. In order to determine whether
the intraluminal toxin was folded correctly in our assays, the
ability of in vitro-translated StxA to inhibit rabbit ribosomes
was examined. StxA was translated into microsomes by using
E. coli lysate as described above. Control reactions were car-
ried out with E. coli lysate, microsomes, and either no plasmid
DNA or plasmid lacking the StxA gene. After translation,
microsomes were washed and then resuspended in PBS con-
taining 0.1% Triton X-100 to destabilize the membrane and
allow leakage of StxA into the supernatant. After residual
microsomal membranes were removed by centrifugation, the
supernatant was added at a 1:100 dilution to rabbit reticulocyte
lysate. After 15 min of incubation at 37°C, during which active
toxin should have inactivated ribosomes, a plasmid encoding
firefly luciferase (Promega Corp.) was added. Translation was
carried out for 30 min, and the resulting luciferase activity was
determined by adding 5 l of the translation product to 100 l
of luciferase substrate and quantifying the light output with a
luminometer. Compared to supernatant derived from the con-
trol reactions, supernatant derived from microsomes contain-
ing recombinant StxA markedly inhibited luciferase translation
(Fig. 4B).
Coimmunoprecipitation of StxA with HEDJ and other ER-
localized chaperones. In yeast, the retrotranslocation of sev-
eral misfolded proteins requires the BiP homologue (Kar2)
and luminal Hsp40 chaperones (6, 16, 18). In order to deter-
mine whether HEDJ, a luminal Hsp40 in human cells, played
a similar role in Stx translocation, coimmunoprecipitation ex-
periments were performed. After in vitro transcription and
translation of toxin into the ER lumen, immunoprecipitation
was performed with antibodies against HEDJ. In addition,
coimmunoprecipitation experiments were performed with an-
tibodies against the intraluminal chaperones BiP, GRP94,
Erp57, and calnexin, all of which are known to interact with at
least a subset of misfolded proteins (8, 12, 13, 32). Our labo-
ratory has recently demonstrated that BiP and Grp94 coimmu-
noprecipitate with HEDJ from ER extracts of untreated Vero,
HepG2, and HTO cells (Marcus and Haslam, unpublished),
suggesting that these chaperones are capable of forming a
complex in the ER. We were therefore particularly interested
in seeing if these chaperones interacted with StxA within the
ER lumen.
In support of the hypothesized role for HEDJ in toxin trans-
location, this chaperone was found to interact with StxA both
in the presence and in the absence of a cross-linker (Fig. 5).
Likewise, StxA was coimmunoprecipitated with BiP and Grp94
both in the presence and in the absence of a cross-linker (Fig.
5). Calnexin was an important negative control in these exper-
iments, as this chaperone interacted with carbohydrate moi-
eties on misfolded glycoproteins and therefore was not ex-
pected to interact directly with StxA, which was not
glycosylated in these experiments, as demonstrated by endogly-
canase digestion of the translated product (data not shown).
Therefore, the small amount of toxin coimmunoprecipitated
with anti-calnexin antibodies after DSP cross-linking may have
represented nonspecific binding of toxin to protein G Sepha-
rose beads. Notably, StxA did not coimmunoprecipitate with
the luminal PDI-like disulfide isomerase Erp57, either in the
presence or in the absence of a cross-linker. Together, the
results of the coimmunoprecipitation experiments demon-
strated that Stx associates within the ER lumen with HEDJ
and, to a lesser extent, with other luminal chaperones.
Next, in order to determine whether HEDJ-associated StxA
was found in a complex with Sec61 or other chaperones, se-
quential immunoprecipitation experiments were performed.
StxA was translated into microsomes, cross-linked with DSP,
and subjected to immunoprecipitation with anti-HEDJ as de-
scribed above. Following the anti-HEDJ immunoprecipitation,
the pellet was resuspended in lysis buffer, heated, and sub-
jected to a second round of immunoprecipitation with antibod-
ies against Sec61, BiP, and Grp94 or with no second antibody
as a control. The amount of StxA isolated after the second
immunoprecipitation represented the toxin that was associated
both with HEDJ and the second targeted chaperone. As ex-
pected, the control experiment, in which no second antibody
FIG. 4. Demonstration that StxA is incorporated into the ER lu-
men and is active. (A) StxA was synthesized by coupled in vitro tran-
scription and translation in the presence of 35S-labeled methionine and
cysteine and ER extracts. The microsomal extract was aliquoted into
three tubes and exposed either to no proteinase K or detergent, to both
proteinase K and detergent, or to proteinase K without detergent.
After 30 min of incubation, the reaction mixtures were subjected to
SDS-PAGE and fluoroscopy to detect residual toxin. (B) StxA was
synthesized by coupled in vitro transcription and translation in the
presence of ER extracts. Microsomes were then permeabilized with
0.1% Triton X-100 and diluted 100-fold with PBS, and 1-l portions
were added to rabbit reticulocyte lysates. As a control, an in vitro
transcription-translation reaction mixture containing empty expression
plasmid was used as the microsome source. After reticulocyte lysates
were treated with Stx or control extracts, a plasmid encoding luciferase
was added, and a second in vitro transcription and translation reaction
was carried out. The amount of luciferase produced was quantified by
adding 5 l of the translation reaction mixture to luciferase substrate,
and the light output was quantified with a luminometer. RLU, relative
light units.
FIG. 5. StxA coimmunoprecipitates with HEDJ and other luminal
ER chaperones. StxA was synthesized by coupled in vitro transcription
and translation in the presence of 35S-labeled methionine and cysteine
and ER extracts. Microsomes were aliquoted and either exposed to a
cross-linker (DSP) () or not cross-linked (). The microsomes were
then washed and subjected to immunoprecipitation with antibodies
against various ER chaperones. The immunoprecipitated material was
boiled and subjected to SDS-PAGE. Coimmunoprecipitated toxin was
detected by fluorography.
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was added, yielded no detectable toxin. In contrast, radiola-
beled StxA was detected after the second immunoprecipitation
with the anti-BiP and anti-Grp94 antibodies (Fig. 6). These
results are consistent with recent findings of Meunier et al.,
who demonstrated that HEDJ/ERdj3 that is associated with
misfolded substrate proteins can be found in association with a
preformed complex that includes BiP and Grp94 (14). More-
over, a significant amount of HEDJ-bound toxin was associ-
ated with Sec61. This result demonstrated that Stx interacts
with HEDJ, and at least a portion of the HEDJ-interacting
toxin was closely associated with the translocon, Sec61.
DISCUSSION
In an attempt to characterize the components of the Stx
trafficking pathway, genetic screening for molecules involved in
intracellular toxin trafficking was performed. Cells were trans-
fected with a Vero cell cDNA library and then selected for Stx
resistance. Plasmid DNA that was presumed to encode a factor
that allowed resistance to the toxin was recovered from resis-
tant cells. One clone was recovered after three rounds of trans-
fection and enrichment and was found to contain a cDNA
encoding the first 124 amino acids of a previously undescribed
protein. Further characterization and cloning of the full-length
cDNA revealed that this gene encodes a novel Hsp40 chaper-
one. An initial characterization demonstrated that this mole-
cule is localized to the ER, where it is able to interact with BiP
and other luminal chaperones (36). The canine and human
homologues of this molecule have been designated Erdj3, and
it has been shown that they also interact with BiP and mis-
folded substrate proteins (1, 28). In analogy with the yeast
ER-associated Hsp40 chaperones, HEDJ likely functions in
recognizing proteins as being misfolded and recruits aberrantly
folded molecules to Sec61 for reverse translocation.
Shiga toxin, like ricin and cholera toxin, has no intrinsic
pore-forming activity, yet all of these toxins must gain access to
the cytosol (22, 24). These toxins require trafficking in a circu-
itous route to the ER, unlike toxins that enter the cytosol
directly from the plasma membrane or from the endosomal
compartment. Lacking the ability to cross membranes, Shiga
toxin and related toxins apparently utilize existing host ma-
chinery to enter the cytosol. It has recently been proposed that
these toxins are able to mimic the structure of an unfolded
protein and thereby utilize the host translocation machinery
for transport from the ER to the cytosol (4, 21).
The process of protein retrotranslocation across the ER
membrane has been studied extensively in yeast. Temperature-
sensitive mutants have revealed central roles for the integral
membrane translocon, Sec61, as well as an Hsp70 known as
BiP (or Kar2), in protein translocation from the ER to the
cytosol. In addition, Jem1p and Scj1p, two Hsp40 family mem-
bers, have been shown to be required for retrotranslocation of
misfolded proteins (16). The identification of HEDJ in a
screening analysis for toxin resistance and the demonstration
that the toxin interacts with this chaperone within the ER
suggest that HEDJ plays a similar role in translocation of
misfolded proteins, as well as Stx, from the mammalian ER.
Hsp40 chaperones are involved in nearly all aspects of pro-
tein synthesis and secretion. Using the genetic screening
method described here, we isolated the first Hsp40 cochaper-
one localized to the ER lumen of human cells. The require-
ment for ER-localized chaperones in retrotranslocation of bac-
terial toxins has not been examined, except for the recent
discovery that transport of cholera toxin requires its unfolding
by a chaperone known as protein disulfide isomerase (33).
Whether Shiga toxin and ricin interact with PDI is not known.
Moreover, the mechanism by which all three of these toxins are
apparently targeted to the Sec61 pore remains unknown. Pre-
sumably, the upstream events include interaction with ER-
localized chaperones that recognize these toxins as misfolded
host proteins and target them for retrotranslocation. Recently,
evidence has accumulated that both ricin and cholera toxin
utilize the Sec61 pore to access the cytoplasm from the ER (16,
27, 29, 33). Based on its similar intracellular trafficking and
inability to cross host membranes, Shiga toxin is also likely to
utilize the Sec61 translocon. Our data suggest that Stx may be
recruited to the Sec61 apparatus by HEDJ and other luminal
ER chaperones.
The structural features of toxins that allow translocation
have not been determined, nor has the role of ER-localized
chaperones in this process been determined. Exposed hydro-
phobic domains have been proposed to be an important signal
for interaction of Hsp70 chaperones with misfolded proteins.
With this in mind, it has been proposed that a hydrophobic
domain located near the carboxyl terminus of StxA, cholera
toxin, and ricin is exposed upon dissociation of the B subunits
and is responsible for recognition of the toxin by host chaper-
ones. In support of a role for this region in toxin translocation,
it has been demonstrated that mutations in the hydrophobic
domain of StxA result in diminished cytotoxicity (31). Whether
this region is crucial for retrotranslocation of any toxin across
the ER membrane has not been tested yet. Targeted mutagen-
esis of toxin and HEDJ should allow molecular dissection of
the residues involved in their interaction and should be facil-
itated by the in vitro binding and transport assays described
here. Ultimately, this information may allow rational design of
pharmacologic agents that inhibit toxin binding to HEDJ and
transport to the host cell cytoplasm.
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